Many existing protocols for neuronal differentiation of human pluripotent cells result in heterogeneous cell populations and unsynchronized differentiation, necessitating the development of methods for labeling specific cell populations. Here we describe how microRNA-regulated lentiviral vectors can be used to visualize specific cell populations by exploiting endogenous microRNA expression patterns. This strategy provides a useful tool for visualization and identification of neural progeny derived from human pluripotent stem cells. We provide detailed protocols for lentiviral transduction, neural differentiation, and subsequent analysis of human embryonic stem cells.
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To track differentiating cell populations, reporter cell lines generated by homologous recombination (knock-in) or via BAC transgenes have been widely used in mouse cells (5) (6) (7) (8) . These strategies provide a robust way to visualize and isolate specific cell populations of differentiated pluripotent stem cells. Although possible, these strategies are often complicated to transfer to human cells due to technical issues (9) , and only a few successful cases have been described (10, 11) . To circumvent these difficulties, we have employed an alternative strategy that exploits the cells' endogenous microRNA (miRNA) machinery (12) . Our approach is simple to use and offers a reporter system that can be as reliable as BAC transgenesis or knock-in technology.
MicroRNAs are small noncoding RNAs of 21-23 nucleotides that negatively regulate gene expression by binding complementary mRNAs and inhibit subsequent protein expression (13) . Our system is based on a lentiviral vector that encodes a fluorescent reporter gene (in this case GFP) and tandem target sites for an miRNA (14, 15) . When a microRNA is present in the cell, it binds to the target sites and downregulates GFP expression, while in cells that do not express the microRNA GFP, it is expressed. Based on this strategy, we used miR-292. It is specifically expressed in pluripotent cells, therefore only allowing GFP expression in differentiated cells (12) . However, the versatility of the system allows the use of any microRNA of choice, including neuron-specific microRNAs (14) .
Here we describe how this system can be used for human embryonic stem cells. We provide detailed protocols for the generation of lentiviral vectors, the transduction of hES-cells, and their differentiation into neurons. Finally, we provide protocols for analyzing these cells through flow cytometry and immunocytochemistry.
All catalog numbers are European.
1. Cell culture lab certified for lentiviral vector production and use.
2. Virkon and tissue culture hood with UV-light.
3. 15-cm tissue culture-treated plastic dishes.
4. Ultracentrifugation tubes (Beckman L 60).
5. 293T cells -must never be grown to confluency. (a) pMD2.G envelope plasmid.
(b) pMDL Gag-Pol plasmid.
(c) pRSV-Rev reverse transcriptase plasmid.
(d) Transfer vector plasmid with reporter gene (i.e., GFP) under control of a constitutively active promoter (i.e., PGK) containing microRNA target sequences in the 3¢UTR (see Note 11 and Fig. 1 ). 13. Ultracentrifuge (Beckman L60).
14. Rotor for ultracentrifuge (Beckman Coulter, SW32).
15. FACS cytometer instrument for flow cytometric analysis of GFP expression.
1. Human ESC line (i.e., H9, HuES10).
2. Tissue culture-treated plasticware (i.e., 6-cm dishes, 6-well plates).
3. Irradiated or mitomycin-C-treated mouse embryonic fibroblasts (MEFs). Caution: All plasticware which has been in contact with virus and with virus-transduced cells for up to 7 days after transduction should be thoroughly decontaminated with Virkon before disposal.
The following lentiviral vector production protocol is based on a calcium phosphate transfection method using a third-generation lentiviral vector system (14, 16, 17) . This protocol can be scaled up as needed.
1. 24 h before transfection, plate 9 × 10 6 293T cells in growth medium in a 15-cm tissue culture dish.
2. 2 h before transfection, change medium to 22.5 mL IMDM medium.
Methods

Lentiviral Vector Production and Titering
3. For transfection, mix plasmids: 9 mg pMDG + 12.5 mg pMDL + 6.25 mg pRSV-Rev + 32 mg transfer vector (microRNAregulated reporter plasmid). Bring the plasmid mix to a final volume of 1,125 mL with 0.1× TE buffer.
4. Add 125 mL 2.5 M CaCl 2 solution to the DNA/TE mix and leave at room temperature for 5 min.
5. While vortexing, add 1,250 mL 2× HBS solution dropwise to the DNA/TE/CaCl 2 mix to form DNA/calcium phosphate precipitate.
6. Add the total precipitate to the 15-cm dish with 293T cells and rock the dish back and forth to distribute the precipitate evenly across the dish.
7. After 12-14 h, change medium to 16 mL fresh IMDM medium.
8. 30-36 h after changing the medium, harvest the viruscontaining supernatant.
9. Spin down the supernatant at 800 × g for 10 min to remove cellular debris and subsequently filter the supernatant with a 0.2-mm filter.
10. Ultracentrifuge the filtered supernatant at 19,500 RPM for 2 h at 4°C.
11. After ultracentrifugation, decant the supernatant and add 100-200 mL PBS to the pellet without pipetting. Leave the pellet in PBS for at least 2 h at 4°C to dissolve the virus particles.
12. Mix and aliquot the viral suspension and store at −80°C.
13. To determine the viral titer, plate 1 × 10 5 293T cells in a 6-well plate and transduce on the same day with various dilutions of virus suspension (i.e. 0.01-3 mL virus suspension) (see Note 1).
14. 3 days later, dissociate the transduced 293T cells with trypsin and spin down in growth medium.
15. Resuspend the cells in 500 mL growth medium with 2% PFA and leave at room temperature for 15 min before FACS analysis (see Note 2).
16. Calculate the concentration of transducing units (TU) per mL, i.e., if 0.1 mL virus suspension results in 7% GFP+ cells of the total population, then 0.01 mL virus suspension contains 0.07 × 100,000 = 7,000 TU → this corresponds to 7 × 10 8 TU/mL (see Note 3).
hESCs are cultured on irradiated or mitomycin-C-treated mouse embryonic fibroblasts (MEFs) in hESC medium. 3. Wash hESCs once in PBS, and add Accutase to dissociate cells (500 mL to a 6-well). Leave cells with Accutase in the incubator for 5-10 min.
4. Use a 1-mL pipette to triturate cells to single cells, and spin down cells in 10 mL hESC medium at 200 × g for 5 min.
5. Wash cells once again in 10 mL hESC medium and spin down. 10. Wash cells once again in 10 mL hESC medium and spin down.
11. Count and plate the transduced hESCs on new MEFs at a concentration of 4 × 10 5 cells/well in 6-well plates in hESC medium with 10 mM Y-27632. Save an aliquot of the cell suspension in media for FACS analysis (i.e., 300 mL cell suspension with a concentration of ³5 × 10 5 cells/mL) (see Notes 2 and 5).
Change medium and expand cells with dispase until sufficient number of cells is obtained for freezing and for performing experiments (see Note 6).
The differentiation protocol described here is based on a previously published protocol for neural induction (1). The protocol can be scaled up as needed. If specific subtypes of neural cells are desired, additional factor can be added to the protocol during differentiation. For the GFP-mir292T construct, GFP will start to turn on at day 4 of differentiation, and it will increase up to day 20 (see Fig. 2b ). 6. Replace this medium on d2 and d4.
7. On d5 of differentiation, replace medium with 75% KSR medium + 25% N2 medium + 10 mM SB431542 and 200 ng/mL noggin.
8. On d7 of differentiation, replace medium with 50% KSR medium + 50% N2 medium + 10 mM SB431542, 200 ng/mL noggin, and 100 ng/mL FGF8a.
9. On d9 of differentiation, replace medium with 25% KSR medium + 75% N2 medium + 100 ng/mL FGF8a, 20 ng/mL BDNF, and 200 mM ascorbic acid.
10. On d10 of differentiation, aspirate differentiation media and add 100 mL Accutase to coat the well. Incubate at 37°C for 15 min or until all cells are rendered to single cells.
11. Triturate the cells in the dish using a 1-mL pipette with additional N2 medium until the cells are in a single cell suspension. 12. Wash and centrifuge cells twice in N2 media.
Neural Differentiation of hESCs
13. Resuspend the cells in N2 media, and determine the cell concentration using a hemocytometer.
14. Adjust the cell concentration to 1 × 10 7 /mL.
15. Plate the cells in droplets onto dried wells coated with polyornithine, fibronectin, and laminin. Spot one or several droplets of 5 mL of the cell suspension in each well and let the cells attach for 15 min in the incubator before adding N2 containing BDNF (20 ng/mL), FGF8a (100 ng/mL), and ascorbic acid (200 mM).
16. Culture cells in this medium for 4-10 days or until mature neuronal cells are visible.
At different timepoints during differentiation, the microRNAregulated GFP levels can be monitored at the protein level either by fluorescence microscopy or flow cytometry on live cells or by staining of fixed cells. For an accurate and quantitative measure of the time course of GFP protein regulation, flow cytometry is the preferable method. Note that some microRNAs regulate their target vector through degradation of the viral mRNA, whereas others exert translational control of reporter protein synthesis. To analyze whether your target vector is regulated at the mRNA or the protein level, a flow cytometric time course analysis of GFP expression must be complemented by a qRT-PCR analysis of viral mRNA levels. For the GFP-mir292T vector, GFP expression in human cells is exclusively regulated at the protein level. Thus, high levels of vector-derived mRNA can be detected both in the pluripotent and the differentiated state, but GFP fluorescence is only detected after differentiation (see Fig. 2b , c)
Staining of transduced cells during differentiation:
(a) Perform differentiations in 48-well plates, and at different timepoints during differentiation, fix the differentiating cells in 4% PFA for 15 min at 37°C. (g) Analyze GFP fluorescence intensity for the live cell population in the FL1 channel (see Note 5 and Fig. 2d ).
Quantitative RT-PCR analysis of viral mRNA levels:
(a) Perform differentiations in 48-well plates, and at different timepoints during differentiation, lyse cells in 350 mL RLT buffer + b-mercaptoethanol, to extract total RNA following the RNeasy kit manual.
(b) Perform cDNA synthesis on 1-5 mg of total RNA, using SuperScript III and random primers following the producer's manual.
(c) Perform real-time quantitative PCR on cDNA using primers for detection of viral mRNA as well as primers for pluripotency and differentiation-associated genes following the Sybr Green manual (see Note 10).
1. With this virus production protocol, it is expected to achieve a total of 1 × 10 7 to 1 × 10 8 TU from one 15 cm dish. 6. Ideally, a transduced cell population should be stable over time; however, we observe some instability of the transgene expression with repeated passaging. This can be due to either silencing of the transgene or selective growth of nontransduced cells in the culture over time. Thus, we recommend that transduced cell populations are passaged no more than six times. After this, a new round of transduction should be performed.
7. The confluency of the cells at the start of differentiation is crucial for the efficiency of differentiation, so it is important that the differentiation is not started before the cells are 80-90% confluent. For H9 cells, if 180,000 cells/well are plated and the quality and survival of the cells are good, then the cells should be ready to start differentiation on the next day. If you wish to start differentiation after 2 days, 130,000-150,000 cells can be plated in stead. To start 3 days later, 100,000 cells can be plated. Note that the survival of the cells will drop exponentially with lower plating densities. The optimal plating densities will depend on the cell line used.
8. When differentiating the cells, the medium volume in the well should be high since the cell density is extremely high and medium is only changed every other day (i.e., use 600-800 mL medium/well for a 48-well plate)
9. In the neural differentiation paradigm, it is relevant to follow the regulation of GFP in parallel with the loss of pluripotency and the acquisition of neural fate. For this purpose, we recommend staining for Oct-3/4 as a marker of pluripotency, Pax6 as a marker of early neural progenitors and bIII-tubulin as a marker of neuronal cells (see Sect. 2.4.5 for antibodies and dilutions). The EGFP reporter protein maintains fluorescent properties after PFA fixation, so it is not normally necessary to stain for GFP.
10. When performing qRT-PCR on viral sequences from transduced cells, it is important to keep in mind that any contamination with genomic DNA or viral plasmid will give rise to a signal which is indistinguishable from that of the viral vector cDNA. Thus, for transduced cells, we recommend that DNase treatment is always included in the RNA purification protocol and that a parallel control lacking SuperScript enzyme is included in the PCR reaction. This control will reveal whether contamination with plasmids or genomic DNA is present in your samples.
11. The optimal design of the microRNA-regulated vector ultimately depends on the cell type and the experimental paradigm. Examples of variations include the choice of promoter, miRNAtarget sequence, and reporter gene. We refer previous papers where it is extensively described how microRNA-regulated lentiviral vectors can be optimized for various purposes (14, 15) . It should be noted that most microRNA-regulated vectors can be transferred between species due to the high degree of conservation among microRNAs. The miR-292T vector used this chapter is based on the sequence of the murine mmu-miR-292 but also works efficiently in human cells due to presence of several close homologues, including hsa-miR-371.
